Compass Therapeutics to Participate in the Stifel 2023 Virtual Targeted Oncology Days
19 Avril 2023 - 2:30PM
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage,
oncology-focused biopharmaceutical company developing proprietary
antibody-based therapeutics to treat multiple human diseases, today
announced that the Company will participate in the Stifel 2023
Virtual Targeted Oncology Days, which is taking place on April 25 –
26, 2023.
Fireside Chat details:
Date: Wednesday, April 26Time: 11
AM ET Webcast:
https://wsw.com/webcast/stifel78/cmpx/2115088
Virtual/Replay availability: The corporate
presentation will be archived for 90 days on Compass’ Events
page.
About Compass TherapeuticsCompass Therapeutics,
Inc. is a clinical-stage, oncology-focused biopharmaceutical
company developing proprietary antibody-based therapeutics to treat
multiple human diseases. Compass’s scientific focus is on the
relationship between angiogenesis, the immune system, and tumor
growth. Compass’s pipeline of novel product candidates is designed
to target multiple critical biological pathways required for an
effective anti-tumor response. These include modulation of the
microvasculature via angiogenesis-targeted agents, induction of a
potent immune response via activators on effector cells in the
tumor microenvironment, and alleviation of immunosuppressive
mechanisms used by tumors to evade immune surveillance. Compass
plans to advance its product candidates through clinical
development as both standalone therapies and in combination with
proprietary pipeline antibodies based on supportive clinical and
nonclinical data. Compass was founded in 2014 and is headquartered
in Boston, Massachusetts. For more information, visit the Compass
Therapeutics, Inc. website at www.compasstherapeutics.com.
Investor Contactir@compasstherapeutics.com
Media ContactAnna Gifford, Communications
Managermedia@compasstherapeutics.com 617-500-8099
Compass Therapeutics (NASDAQ:CMPX)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Compass Therapeutics (NASDAQ:CMPX)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024